|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM314962921 |
| 003 |
DE-627 |
| 005 |
20231225153857.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202003800
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1049.xml
|
| 035 |
|
|
|a (DE-627)NLM314962921
|
| 035 |
|
|
|a (NLM)32924217
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Zhao, Di
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Electromagnetized-Nanoparticle-Modulated Neural Plasticity and Recovery of Degenerative Dopaminergic Neurons in the Mid-Brain
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 19.07.2021
|
| 500 |
|
|
|a Date Revised 19.07.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2020 Wiley-VCH GmbH.
|
| 520 |
|
|
|a The degeneration of dopaminergic neurons is a major contributor to the pathogenesis of mid-brain disorders. Clinically, cell therapeutic solutions, by increasing the neurotransmitter dopamine levels in the patients, are hindered by low efficiency and/or side effects. Here, a strategy using electromagnetized nanoparticles to modulate neural plasticity and recover degenerative dopamine neurons in vivo is reported. Remarkably, electromagnetic fields generated by the nanoparticles under ultrasound stimulation modulate intracellular calcium signaling to influence synaptic plasticity and control neural behavior. Dopaminergic neuronal functions are reversed by upregulating the expression tyrosine hydroxylase, thus resulting in ameliorating the neural behavioral disorders in zebrafish. This wireless tool can serve as a viable and safe strategy for the regenerative therapy of the neurodegenerative disorders
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a dopaminergic neurons
|
| 650 |
|
4 |
|a electromagnetized nanoparticles
|
| 650 |
|
4 |
|a neural plasticity
|
| 650 |
|
4 |
|a regenerative therapy
|
| 650 |
|
4 |
|a remote control
|
| 650 |
|
7 |
|a Biocompatible Materials
|2 NLM
|
| 650 |
|
7 |
|a Tyrosine 3-Monooxygenase
|2 NLM
|
| 650 |
|
7 |
|a EC 1.14.16.2
|2 NLM
|
| 700 |
1 |
|
|a Feng, Pei-Jian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Jia-Hao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Dong, Mei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shen, Xiao-Quan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Ying-Xin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shen, Qun-Dong
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 32(2020), 43 vom: 26. Okt., Seite e2003800
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:32
|g year:2020
|g number:43
|g day:26
|g month:10
|g pages:e2003800
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202003800
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 32
|j 2020
|e 43
|b 26
|c 10
|h e2003800
|